Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

397 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rituximab in combination with cyclosporine and steroid pulse therapy for childhood-onset multidrug-resistant nephrotic syndrome: a multicenter single-arm clinical trial (JSKDC11 trial).
Nozu K, Sako M, Tanaka S, Kano Y, Ohwada Y, Morohashi T, Hamada R, Ohtsuka Y, Oka M, Kamei K, Inaba A, Ito S, Sakai T, Kaito H, Shima Y, Ishikura K, Nakamura H, Nakanishi K, Horinouchi T, Konishi A, Omori T, Iijima K. Nozu K, et al. Among authors: sako m. Clin Exp Nephrol. 2024 Apr;28(4):337-348. doi: 10.1007/s10157-023-02431-0. Epub 2023 Nov 27. Clin Exp Nephrol. 2024. PMID: 38010466 Free PMC article. Clinical Trial.
Rituximab Treatment for Nephrotic Syndrome in Children.
Iijima K, Sako M, Nozu K. Iijima K, et al. Among authors: sako m. Curr Pediatr Rep. 2015;3(1):71-77. doi: 10.1007/s40124-014-0065-5. Curr Pediatr Rep. 2015. PMID: 25741456 Free PMC article.
Rituximab for nephrotic syndrome in children.
Iijima K, Sako M, Nozu K. Iijima K, et al. Among authors: sako m. Clin Exp Nephrol. 2017 Apr;21(2):193-202. doi: 10.1007/s10157-016-1313-5. Epub 2016 Jul 15. Clin Exp Nephrol. 2017. PMID: 27422620 Free PMC article. Review.
Long-term outcome of childhood-onset complicated nephrotic syndrome after a multicenter, double-blind, randomized, placebo-controlled trial of rituximab.
Kamei K, Ishikura K, Sako M, Aya K, Tanaka R, Nozu K, Kaito H, Nakanishi K, Ohtomo Y, Miura K, Takahashi S, Morimoto T, Kubota W, Ito S, Nakamura H, Iijima K; Rituximab for Childhood-Onset Refractory Nephrotic Syndrome (RCRNS) Study Group. Kamei K, et al. Among authors: sako m. Pediatr Nephrol. 2017 Nov;32(11):2071-2078. doi: 10.1007/s00467-017-3718-0. Epub 2017 Jun 29. Pediatr Nephrol. 2017. PMID: 28664242 Clinical Trial.
Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial).
Hama T, Nakanishi K, Ishikura K, Ito S, Nakamura H, Sako M, Saito-Oba M, Nozu K, Shima Y, Iijima K, Yoshikawa N; Japanese Study Group of Kidney Disease in Children (JSKDC). Hama T, et al. Among authors: sako m. BMC Nephrol. 2018 Sep 10;19(1):223. doi: 10.1186/s12882-018-1033-z. BMC Nephrol. 2018. PMID: 30200895 Free PMC article. Clinical Trial.
Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
Horinouchi T, Sako M, Nakanishi K, Ishikura K, Ito S, Nakamura H, Oba MS, Nozu K, Iijima K. Horinouchi T, et al. Among authors: sako m. BMC Nephrol. 2018 Nov 1;19(1):302. doi: 10.1186/s12882-018-1099-7. BMC Nephrol. 2018. PMID: 30382824 Free PMC article. Clinical Trial.
397 results